Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
University of Michigan (INC)
Search grants from University of Michigan (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Identifying the sequences and factors that govern the fate of elongating RNAPII
Analysis of the Molecular Mechanisms of Telomerase Recruitment to Telomeres and Telomerase Catalysis
RXR-Heterodimeric Receptors in the GI Tract
Metabolic Control of Cardiac Electrical Activity
The Arecibo High Frequency (HF) Facility: An Instrument to Study Ionospheric Physics
Recently added grants:
Platelet Reprogramming During Inflammation
Neural Metabolic Stress in mTBI and PTSD
Signaling Pathways and Therapeutic Targeting of Leukemic Cells
The Role of Effort Discounting in the Link between Insomnia and Depression
Preventing Diabetic Foot Ulcers through Manipulating the Skin Microbiota
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025025-000
Application #
6688658
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Michigan (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
/ University of Michigan (INC)
NIH 2002
N01 CA
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
/ University of Michigan (INC)
Comments
Be the first to comment on this grant